{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T22:01:10Z","timestamp":1747173670871,"version":"3.40.5"},"reference-count":36,"publisher":"Cambridge University Press (CUP)","license":[{"start":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T00:00:00Z","timestamp":1536796800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Prim Health Care Res Dev"],"published-print":{"date-parts":[[2019]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec id=\"S1463423618000580_abs1\" sec-type=\"general\"><jats:title>Aim<\/jats:title><jats:p>This study aimed to assess the consistency and replicability of these process measures during provision of the Italian Medicines Use Review (I-MUR).<\/jats:p><\/jats:sec><jats:sec id=\"S1463423618000580_abs2\" sec-type=\"general\"><jats:title>Background<\/jats:title><jats:p>Medication review is a common intervention provided by community pharmacists in many countries, but with little evidence of consistency and replicability. The I-MUR utilised a standardised question template in two separate large-scale studies. The template facilitated pharmacists in recording medicines and problems reported by patients, the pharmaceutical care issues (PCIs) they found and actions they took to improve medicines use.<\/jats:p><\/jats:sec><jats:sec id=\"S1463423618000580_abs3\" sec-type=\"methods\"><jats:title>Methods<\/jats:title><jats:p>Community pharmacists from four cities and across 15 regions were involved in the two studies. Patients included were adults with asthma. Medicines use, adherence, asthma problems, PCIs and actions taken by pharmacists were compared across studies to assess consistency and replicability of I-MUR.<\/jats:p><\/jats:sec><jats:sec id=\"S1463423618000580_abs4\" sec-type=\"general\"><jats:title>Findings<\/jats:title><jats:p>The total number of pharmacists and patients completing the studies was 275 and 1711, respectively. No statistically significant differences were found between the studies in the following domains: patients\u2019 demographic, patients\u2019 perceived problems, adherence, asthma medicines used and healthy living advice provided by pharmacists. The proportion of patients in which pharmacists identified PCIs was similar across both studies. There were differences only in the incidence of non-steroidal anti-inflammatory drug use, the frequency of potential drug-disease interactions and in the types of advice given to patients and GPs.<\/jats:p><\/jats:sec><jats:sec id=\"S1463423618000580_abs5\" sec-type=\"conclusions\"><jats:title>Conclusions<\/jats:title><jats:p>The use of a standardised template for the I-MUR may have contributed to a degree of consistency in the issues found, which suggests this intervention could have good replicability.<\/jats:p><\/jats:sec>","DOI":"10.1017\/s1463423618000580","type":"journal-article","created":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T03:26:07Z","timestamp":1536809167000},"update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":3,"title":["Consistency and replicability of a pharmacist-led intervention for asthma patients: Italian Medicines Use Review (I-MUR)"],"prefix":"10.1017","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3457-9981","authenticated-orcid":false,"given":"Andrea","family":"Manfrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4148-5652","authenticated-orcid":false,"given":"Janet","family":"Krska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2018,9,13]]},"reference":[{"volume-title":"Medicines optimisation: helping patients to make the most of medicines. Good practice guidance for healthcare professionals in England","year":"2013","author":"Picton","key":"S1463423618000580_ref34"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref29","DOI":"10.1345\/aph.1G180"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref27","DOI":"10.1186\/s12913-015-0791-6"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref25","DOI":"10.5301\/tj.5000644"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref23","DOI":"10.1111\/j.2042-7174.2002.tb00593.x"},{"key":"S1463423618000580_ref22","first-page":"656","article-title":"Providing pharmaceutical care using a systematic approach","volume":"265","author":"Krska","year":"2000","journal-title":"Pharmaceutical Journal"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref30","DOI":"10.1155\/2003\/736042"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref19","DOI":"10.1186\/s12875-016-0577-x"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref16","DOI":"10.1136\/thx.2005.055699"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref14","DOI":"10.1016\/j.rmed.2013.05.014"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref13","DOI":"10.1183\/13993003.01497-2015"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref11","DOI":"10.1183\/09031936.00075614"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref10","DOI":"10.1046\/j.0269-4727.2003.00507.x"},{"unstructured":"Centre for Policy on Ageing (CPA) (2014) Rapid review. Retrieved 4 December 2017 from http:\/\/www.cpa.org.uk\/information\/reviews\/CPA-Rapid-Review-Community-Pharmacy-Medication-Reviews.pdf.","key":"S1463423618000580_ref7"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref6","DOI":"10.1331\/154434506776180658"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref5","DOI":"10.1007\/s11096-011-9506-1"},{"key":"S1463423618000580_ref4","first-page":"69","article-title":"A holistic and integrated approach to implementing cognitive pharmaceutical services","volume":"51","author":"Benrimoj","year":"2010","journal-title":"ARS Pharmaceutica"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref3","DOI":"10.1136\/thorax.58.10.851"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref2","DOI":"10.3109\/02770903.2012.754463"},{"unstructured":"Goldman M (2008) Statistics for bioinformatics. Retrieved 4 December 2017 from http:\/\/www.stat.berkeley.edu\/~mgoldman\/Section0402.pdf.","key":"S1463423618000580_ref15"},{"unstructured":"Wright D (2016) A rapid review of evidence regarding clinical services commissioned from community pharmacies. 2016. Commissioned by the Chief Pharmaceutical Officer for England to inform the Murray Review of clinical services in community pharmacy. Retrieved 6 January 2017 from https:\/\/www.england.nhs.uk\/commissioning\/wp-content\/uploads\/sites\/12\/2016\/12\/rapid-evdnc-rev-dec-16.pdf.","key":"S1463423618000580_ref37"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref32","DOI":"10.1046\/j.1365-2710.2000.00276.x"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref36","DOI":"10.1177\/00912700122010438"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref28","DOI":"10.1186\/s12913-017-2245-9"},{"key":"S1463423618000580_ref17","first-page":"551","article-title":"Improving drug therapy for patients with asthma\u2014Part 2: use of antiasthma medications","volume":"41","author":"Herborg","year":"2001","journal-title":"Journal of the American Pharmaceutical Association"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref35","DOI":"10.1345\/aph.1E045"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref1","DOI":"10.1136\/thx.2006.064709"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref33","DOI":"10.2147\/IJGM.S157050"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref21","DOI":"10.1111\/j.1365-2125.2007.03022.x"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref26","DOI":"10.5750\/ejpch.v6i2.1463"},{"unstructured":"Italian Government . Legge 69\/2009 e D.LGS 153\/2009: Nuovi Servizi in Farmacia. DECRETO LEGISLATIVO 3 ottobre 2009, n. 153. Individuazione di nuovi servizi erogati dalle farmacie nell\u2019ambito del Servizio sanitario nazionale, nonche\u2019 disposizioni in materia di indennita\u2019 di residenza per i titolari di farmacie rurali, a norma dell\u2019articolo 11 della legge 18 giugno 2009, n. 69. (09G0162). Retrieved 16 April 2013 from http:\/\/gazzette.comune.jesi.an.it\/2009\/257\/2.htm.","key":"S1463423618000580_ref20"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref8","DOI":"10.1592\/phco.21.15.1196.33894"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref12","DOI":"10.14260\/jemds\/2015\/2219"},{"volume-title":"The definition of quality and approaches assessment","year":"1980","author":"Donabedian","key":"S1463423618000580_ref9"},{"doi-asserted-by":"publisher","key":"S1463423618000580_ref31","DOI":"10.1183\/09031936.00112007"},{"unstructured":"Hinchliffe A (2011) Medicines use review by community pharmacists, Public Health Wales Pharmacist-led medication review for older people in the community setting. Public Health Wales, Version: Final 1.0, 1-28.","key":"S1463423618000580_ref18"}],"container-title":["Primary Health Care Research &amp; Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1463423618000580","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T02:51:43Z","timestamp":1559962303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1463423618000580\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,13]]},"references-count":36,"alternative-id":["S1463423618000580"],"URL":"https:\/\/doi.org\/10.1017\/s1463423618000580","relation":{},"ISSN":["1463-4236","1477-1128"],"issn-type":[{"type":"print","value":"1463-4236"},{"type":"electronic","value":"1477-1128"}],"subject":[],"published":{"date-parts":[[2018,9,13]]},"assertion":[{"value":"\u00a9 Cambridge University Press 2018","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http:\/\/creativecommons.org\/licenses\/by\/4.0\/), which permits nrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}],"article-number":"e10"}}